BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28322108)

  • 41. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer.
    Shitole AA; Sharma N; Giram P; Khandwekar A; Baruah M; Garnaik B; Koratkar S
    Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111035. PubMed ID: 32994029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
    Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
    Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery.
    Oyarzun-Ampuero FA; Rivera-Rodríguez GR; Alonso MJ; Torres D
    Eur J Pharm Sci; 2013 Jul; 49(4):483-90. PubMed ID: 23684914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
    Chiang CS; Tseng YH; Liao BJ; Chen SY
    Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models.
    Hirsjärvi S; Dufort S; Gravier J; Texier I; Yan Q; Bibette J; Sancey L; Josserand V; Passirani C; Benoit JP; Coll JL
    Nanomedicine; 2013 Apr; 9(3):375-87. PubMed ID: 22960195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Two Types of Melatonin-Loaded Nanocapsules with Distinct Supramolecular Structures: Polymeric (NC) and Lipid-Core Nanocapsules (LNC) on Bovine Embryo Culture Model.
    Komninou ER; Remião MH; Lucas CG; Domingues WB; Basso AC; Jornada DS; Deschamps JC; Beck RC; Pohlmann AR; Bordignon V; Seixas FK; Campos VF; Guterres SS; Collares T
    PLoS One; 2016; 11(6):e0157561. PubMed ID: 27310006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer.
    Kumar V; Mondal G; Slavik P; Rachagani S; Batra SK; Mahato RI
    Mol Pharm; 2015 Apr; 12(4):1289-98. PubMed ID: 25679326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gold nanorod-loaded (PLGA-PEG) nanocapsules as near-infrared controlled release model of anticancer therapeutics.
    Darwish WMA; Bayoumi NA
    Lasers Med Sci; 2020 Oct; 35(8):1729-1740. PubMed ID: 31965353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.
    Onishi H; Katano M
    World J Gastroenterol; 2014 Mar; 20(9):2335-42. PubMed ID: 24605030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PEGylated meloxicam-loaded nanocapsules reverse in vitro damage on caspase activity and do not induce toxicity in cultured human lymphocytes and mice.
    Nishihira VSK; Fontana BD; Ianiski FR; de Almeida HS; Posser CP; Dias JB; Parodi CB; Piva MM; Gris A; Mendes RE; Duarte MMMF; Sagrillo MR; Luchese C; Rech VC; Vaucher RA
    Biomed Pharmacother; 2018 Nov; 107():1259-1267. PubMed ID: 30257340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway.
    Li SH; Fu J; Watkins DN; Srivastava RK; Shankar S
    Mol Cell Biochem; 2013 Jan; 373(1-2):217-27. PubMed ID: 23129257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer.
    Matthaiou EI; Barar J; Sandaltzopoulos R; Li C; Coukos G; Omidi Y
    Int J Nanomedicine; 2014; 9():1855-70. PubMed ID: 24790428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer.
    Borrajo E; Abellan-Pose R; Soto A; Garcia-Fuentes M; Csaba N; Alonso MJ; Vidal A
    J Control Release; 2016 Sep; 238():263-271. PubMed ID: 27476608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumour targeting of lipid nanocapsules grafted with cRGD peptides.
    Hirsjärvi S; Belloche C; Hindré F; Garcion E; Benoit JP
    Eur J Pharm Biopharm; 2014 May; 87(1):152-9. PubMed ID: 24361535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimuli responsive PEGylated bismuth selenide hollow nanocapsules for fluorescence/CT imaging and light-driven multimodal tumor therapy.
    Sun L; Li Q; Zhang L; Chai H; Yu L; Xu Z; Kang Y; Xue P
    Biomater Sci; 2019 Jul; 7(7):3025-3040. PubMed ID: 31115395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease.
    de Mello CG; Branquinho RT; Oliveira MT; Milagre MM; Saúde-Guimarães DA; Mosqueira VC; Lana Md
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5215-22. PubMed ID: 27324760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery.
    Fang YP; Wu PC; Huang YB; Tzeng CC; Chen YL; Hung YH; Tsai MJ; Tsai YH
    Int J Nanomedicine; 2012; 7():4995-5005. PubMed ID: 23055719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted pharmacokinetics of polymeric micelles modified with glycyrrhetinic acid and hydrazone bond in H22 tumor-bearing mice.
    Zheng Y; Shi S; Liu Y; Zhao Y; Sun Y
    J Biomater Appl; 2019 Jul; 34(1):141-151. PubMed ID: 30987507
    [No Abstract]   [Full Text] [Related]  

  • 59. Magnetic core-shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas.
    Fang JH; Lai YH; Chiu TL; Chen YY; Hu SH; Chen SY
    Adv Healthc Mater; 2014 Aug; 3(8):1250-60. PubMed ID: 24623647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node.
    Alonso-Nocelo M; Abellan-Pose R; Vidal A; Abal M; Csaba N; Alonso MJ; Lopez-Lopez R; de la Fuente M
    J Nanobiotechnology; 2016 Jun; 14(1):51. PubMed ID: 27339609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.